This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banik, S. S. R.
Right arrow Articles by Counter, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banik, S. S. R.
Right arrow Articles by Counter, C. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2002, p. 6234-6246, Vol. 22, No. 17
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.17.6234-6246.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

C-Terminal Regions of the Human Telomerase Catalytic Subunit Essential for In Vivo Enzyme Activity

Soma S. R. Banik,1 Chuanhai Guo,1 Allyson C. Smith,1 Seth S. Margolis,1 D. Ashley Richardson,1 Carlos A. Tirado,2 and Christopher M. Counter1,3*

Departments of Pharmacology and Cancer Biology,1 Pathology,2 Radiation Oncology, Duke University Medical Center, Durham, North Carolina 277103

Received 3 December 2001/ Returned for modification 6 January 2002/ Accepted 17 May 2002

Most human cancer cells are thought to acquire the ability to divide beyond the capacity of normal somatic cells through illegitimately activating the gene hTERT, which encodes the catalytic subunit of telomerase. While telomerase reverse transcriptase (TERT) is conserved in most eukaryotes, mounting evidence suggests that the C terminus of the human protein may have functions unique to higher eukaryotes. To search for domains responsible for such functions, we assayed a panel of tandem substitution mutations encompassing this region of human TERT for in vitro and in vivo functionality. We found four clusters of mutations that inactivated the biochemical and biological functions of telomerase, separated by mutations that had little or no effect on enzyme activity. We also identified a region where mutations generate catalytically active but biologically inert proteins. This C-terminal region that dissociates activities of telomerase (C-DAT) does not appear to be involved in nuclear localization or protein multimerization. Instead, it appears that the C-DAT region is involved in a step of in vivo telomere synthesis after the assembly of a catalytically active enzyme. Intriguingly, all of the described regions reside in a portion of TERT that is dispensable for cellular viability in yeast, arguing for a divergent role of the C terminus in higher eukaryotes.

* Corresponding author. Mailing address: Departments of Pharmacology and Cancer Biology, Duke University Medical Center, Box 3813, Durham, NC 27710. Phone: (919) 684-9890. Fax: (919) 684-8958. E-mail: count004{at}mc.duke.edu.

Molecular and Cellular Biology, September 2002, p. 6234-6246, Vol. 22, No. 17
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.17.6234-6246.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Wells, T. B., Zhang, G., Harley, Z., Vaziri, H. (2009). Genetic Hypervariability in Two Distinct Deuterostome Telomerase Reverse Transcriptase Genes and their Early Embryonic Functions. Mol. Biol. Cell 20: 464-480 [Abstract] [Full Text]  
  • Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., Garcia, C. K. (2008). Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med. 178: 729-737 [Abstract] [Full Text]  
  • Garcia, C. K., Wright, W. E., Shay, J. W. (2007). Human diseases of telomerase dysfunction: insights into tissue aging. Nucleic Acids Res 35: 7406-7416 [Abstract] [Full Text]  
  • Wittmann, B. M., Sherk, A., McDonnell, D. P. (2007). Definition of Functionally Important Mechanistic Differences among Selective Estrogen Receptor Down-regulators. Cancer Res. 67: 9549-9560 [Abstract] [Full Text]  
  • Wyatt, H. D. M., Lobb, D. A., Beattie, T. L. (2007). Characterization of Physical and Functional Anchor Site Interactions in Human Telomerase. Mol. Cell. Biol. 27: 3226-3240 [Abstract] [Full Text]  
  • Xin, Z.-T., Beauchamp, A. D., Calado, R. T., Bradford, J. W., Regal, J. A., Shenoy, A., Liang, Y., Lansdorp, P. M., Young, N. S., Ly, H. (2007). Functional characterization of natural telomerase mutations found in patients with hematologic disorders. Blood 109: 524-532 [Abstract] [Full Text]  
  • Mosher, R. A., Durrant, W. E., Wang, D., Song, J., Dong, X. (2006). A Comprehensive Structure-Function Analysis of Arabidopsis SNI1 Defines Essential Regions and Transcriptional Repressor Activity. Plant Cell 18: 1750-1765 [Abstract] [Full Text]  
  • Middleman, E. J., Choi, J., Venteicher, A. S., Cheung, P., Artandi, S. E. (2006). Regulation of Cellular Immortalization and Steady-State Levels of the Telomerase Reverse Transcriptase through Its Carboxy-Terminal Domain.. Mol. Cell. Biol. 26: 2146-2159 [Abstract] [Full Text]  
  • MORIARTY, T. J., MARIE-EGYPTIENNE, D. T., AUTEXIER, C. (2005). Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase. RNA 11: 1448-1460 [Abstract] [Full Text]  
  • Moriarty, T. J., Ward, R. J., Taboski, M. A.S., Autexier, C. (2005). An Anchor Site-Type Defect in Human Telomerase That Disrupts Telomere Length Maintenance and Cellular Immortalization. Mol. Biol. Cell 16: 3152-3161 [Abstract] [Full Text]  
  • Masutomi, K., Possemato, R., Wong, J. M. Y., Currier, J. L., Tothova, Z., Manola, J. B., Ganesan, S., Lansdorp, P. M., Collins, K., Hahn, W. C. (2005). The telomerase reverse transcriptase regulates chromatin state and DNA damage responses. Proc. Natl. Acad. Sci. USA 102: 8222-8227 [Abstract] [Full Text]  
  • Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., Young, N. S. (2005). Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia. NEJM 352: 1413-1424 [Abstract] [Full Text]  
  • Banik, S. S. R., Counter, C. M. (2004). Characterization of Interactions between PinX1 and Human Telomerase Subunits hTERT and hTR. J. Biol. Chem. 279: 51745-51748 [Abstract] [Full Text]  
  • Khurts, S., Masutomi, K., Delgermaa, L., Arai, K., Oishi, N., Mizuno, H., Hayashi, N., Hahn, W. C., Murakami, S. (2004). Nucleolin Interacts with Telomerase. J. Biol. Chem. 279: 51508-51515 [Abstract] [Full Text]  
  • Armbruster, B. N., Linardic, C. M., Veldman, T., Bansal, N. P., Downie, D. L., Counter, C. M. (2004). Rescue of an hTERT Mutant Defective in Telomere Elongation by Fusion with hPot1. Mol. Cell. Biol. 24: 3552-3561 [Abstract] [Full Text]  
  • Lee, S. R., Wong, J. M. Y., Collins, K. (2003). Human Telomerase Reverse Transcriptase Motifs Required for Elongation of a Telomeric Substrate. J. Biol. Chem. 278: 52531-52536 [Abstract] [Full Text]  
  • Huard, S., Moriarty, T. J., Autexier, C. (2003). The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity. Nucleic Acids Res 31: 4059-4070 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»